Drugmakers file more patents to thwart generic rivals; Novo's Wegovy data has doctors seeing new possibilities

Taking stock of the drug industry, from the lab to the medicine chest

August 8, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | More drugmakers are filing continuation patents that sideline generic competition The use of continuation patents is hardly new, but the analysis underscores a need to review how patents are awarded. By Ed Silverman STAT+ | Wegovy cardiovascular study has doctors seeing new possibilities in weight loss drug Results of a five-year study of weight loss drug Wegovy have doctors welcoming the heart health benefits found in Novo Nordisk's SELECT trial. By Simar Bajaj and Tara Bannow and Bob Herman and Annalisa Merelli STAT+ | Beleaguered drug manufacturer Emergent cuts jobs, executive role in business shake-up The company announced it will cut 400 jobs and eliminate the role of chief operating officer as part of a shift in focus. By Allison DeAngelis Adobe STAT+ | Novo's obesity drug Wegovy lowers cardiovascular risk by 20%, landmark trial finds The Wegovy trial results are a major boon for Novo Nordisk and other companies developing obesity medications. By Elaine Chen and Andrew Joseph STAT+ | More regulation could be coming for drug ads The FDA may soon decide whether to crack down on distracting visuals in television drug ads or require subtitles about side effects. By John Wilkerson Are biotech VCs headed for better times? In one firm's success, lessons for turning crisis into profit The story of one fund overseen by The Column Group shows how venture capital firms might steer out of a slump into brighter times. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser